Mexico vs Turkey: Cancer death rate by age group
Mexico
2.36 deaths per 100,000 people
in 2022
Turkey
2.37 deaths per 100,000 people
in 2023
Mexico rank
45th
Turkey rank
44th
Cancer death rate by age group over time
- Mexico
- Turkey
How they compare
Turkey currently reports 2.37 deaths per 100,000 people against 2.36 deaths per 100,000 people in Mexico, a difference of 0.01 deaths per 100,000 people.
The two have swapped places 5 times across 14 shared years of data; in 2009 it was Turkey ahead.
Mexico ranks 45th and Turkey ranks 44th of 111 countries.
Across the 3 decades both report, Mexico averaged higher in 2 and Turkey in 1.
Head to head by decade
| Decade | Mexico | Turkey | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.79 deaths per 100,000 people | 6.03 deaths per 100,000 people | 3.24 deaths per 100,000 people | Turkey |
| 2010s | 3.07 deaths per 100,000 people | 2.84 deaths per 100,000 people | 0.2306 deaths per 100,000 people | Mexico |
| 2020s | 2.53 deaths per 100,000 people | 1.93 deaths per 100,000 people | 0.6028 deaths per 100,000 people | Mexico |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rate by age group, Mexico or Turkey?
- Turkey, at 2.37 deaths per 100,000 people against 2.36 deaths per 100,000 people in Mexico as of 2023.
- What is the difference in cancer death rate by age group between Mexico and Turkey?
- 0.01 deaths per 100,000 people, with Turkey ahead.
- How many years of comparable data are there for Mexico and Turkey?
- 14 years are reported by both, from 2009 to 2022.
- How do Mexico and Turkey rank globally for cancer death rate by age group?
- Mexico ranks 45th and Turkey ranks 44th of 111 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rate by age group. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged less than 1 year.